Nature CommunicationsCost-effective non-additive GWAS across 2329 diseases in 500,349 individualsIvan MolotkovMitja KurkiAarno PalotieMark J. DalyMykyta Artomov2025-12-13Full textDOI https://doi.org/10.1038/s41467-025-67277-4